More on JUNS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Jupiter Neurosciences (NQ:JUNS)
Delayed: 2.78 -0.02 (0.71%)
Prev. Close $2.80  
Open$2.78 
52 Wk High$ 
52 Wk Low$ 
Day High$2.80 
Day Low$2.63 
P/E N/A  
EPS$ 
Volume28,676 

Friends, Peers and Foes (?): PHIO, ZENA, ACCS, AREB, ASNS (more...)

Oct 13, 2026 06:01 AM Form S-8 JUPITER NEUROSCIENCES,
Oct 6, 2026 11:15 AM Jupiter Neurosciences doses first patient in Parkinson's Phase 2a trial
Oct 6, 2026 11:15 AM Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
Sep 25, 2026 06:02 AM Form S-3 JUPITER NEUROSCIENCES,
Sep 22, 2026 11:59 AM Form SCHEDULE 13G JUPITER NEUROSCIENCES, Filed by: PharmAla Biotech Holdings Inc.
Aug 28, 2026 05:02 PM Form SCHEDULE 13G/A JUPITER NEUROSCIENCES, Filed by: Orca Capital AG
Aug 28, 2026 05:00 PM Form SCHEDULE 13G JUPITER NEUROSCIENCES, Filed by: Orca Capital AG
Aug 28, 2026 04:06 PM Form 8-K JUPITER NEUROSCIENCES, For: Aug 27
Aug 27, 2026 06:31 AM Form 8-K JUPITER NEUROSCIENCES, For: Aug 26
Aug 24, 2026 04:53 PM Form 8-K JUPITER NEUROSCIENCES, For: Aug 24
View All Articles

Entities mentioned with JUNS

View All Entities